Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: OTC US
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Health Care Supplies

Cardiovascular Sciences Inc

+ Add to Watchlist

CVSC:US

0.0000 USD 0.0001 100.00%

As of 20:10:01 ET on 04/23/2015.

Price not available for CVSC:US

Snapshot for Cardiovascular Sciences Inc (CVSC)

Open: 0.0000 Day's Range: 0.0000 - 0.0000 Volume: 150
Previous Close: 0.0001 52wk Range: 0.0001 - 0.0002 1-Yr Rtn: -

Stock Chart for CVSC

No chart data available.
  • CVSC:US 0.0000
  • 1D
  • 1M
  • 1Y
0.0001
Interactive CVSC Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for CVSC

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPX -
Earnings Per Share (ttm) -2,000.0000
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 0.00
Shares Outstanding (M) 15.19
30 Day Average Volume 0
Price/Book (mrq) 0.0000
Price/Sale (ttm) 0.0000
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CVSC

No data available

Company Profile & Key Executives for CVSC

Cardiovascular Sciences, Inc. develops medical products. The Company owns the rights to intellectual property regarding anti-adhesion products to prevent post-surgical scarring, a method of treating patients suffering from cardiac trauma, a coating that prevents blood clotting on medical devices, and a biocompatible human vascular tissue equivalent for artery replacement.

John MartinChairman/FounderLawrence H Hooper Jr "Larry"Chief Executive Officer
James B DeinleinDir:Mktg/Mgr:IT & Facilities
More Company Profile & Key Executives for CVSC

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil